Cristina M. Kuon Yeng Escalante

Cristina M. Kuon Yeng Escalante

Auto-generated profile, based on publicly available information

Cristina M. Kuon Yeng Escalante

Department of Radiology, Thomas Jefferson University, Philadelphia, PA, United States; Internal Medicine Residency Program, UTRGV Valley Baptist Medical Center, Harlingen, TX, United States

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in Radiology
Verified
Journal Article
Closed access
ALAndrej Lyshchik
Andrej Lyshchik
CECristina Kuon Yeng Escalante
Cristina Kuon Yeng Escalante
TXTania Siu Xiao
Tania Siu Xiao
FPFabio Piscaglia
Fabio Piscaglia
YKYuko Kono
Yuko Kono
ASAmit Singal
Amit Singal
Contrast-enhanced US Liver Imaging Reporting and Data System (LI-RADS) could resolve some indeterminate liver observations (categorized as LR-4 and LR-M at CT or MRI), having a particularly high clinical effect for observations measuring at least 20 mm.

29 October 2024 in Journal of Ultrasound in Medicine
Verified
Journal Article
Open access
CECristina M. Kuon Yeng Escalante
Cristina M. Kuon Yeng Escalante
TXTania Siu Xiao
Tania Siu Xiao
YKYuko Kono
Yuko Kono
FPFabio Piscaglia
Fabio Piscaglia
SWStephanie R. Wilson
Stephanie R. Wilson
CGCEUS LI‐RADS Trial Group
CEUS LI‐RADS Trial Group
Objectives: Contrast‐enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI‐RADS) is used to definitively diagnose hepatocellular carcinoma (HCC) in patients at risk. However, the user variability associated with CEUS LI‐RADS has not been validated in North American and European patients. This study aims to evaluate the inter‐reader agreements of CEUS LI‐RADS features for, and final categorization of, HCC in patients at risk.Methods: This retrospective multicenter clinical study used the database of a previous prospective multinational study, evaluating the accuracy of CEUS LI‐RADS for HCC diagnosis in patients at risk. All cases were first evaluated by a site physician performing/supervising the CEUS examination. Randomly selected cases were re‐evaluated by a blinded central reader. Final diagnosis was confirmed with the reference standard, which was a composite of imaging tests and histology. Cohen's kappa test was used to evaluate inter‐reader agreement.Results: This study included 150 liver nodules and 58.0% (87/150) were confirmed as HCC, 4.7% (7/150) non‐HCC malignancies, 22.7% (34/150) had no confirmed final diagnosis, and 14.7% (22/150) were nonmalignant. Inter‐reader agreements were substantial for CEUS LI‐RADS categorization (κ = 0.61; 95% confidence interval [CI]: 0.51–0.71) and major features assessment (ranged κ = 0.64–0.78), LR‐5 (κ = 0.65; 95% CI: 0.52–0.77), and LR‐M (κ = 0.67; 95% CI: 0.44–0.90), while for LR‐1 and LR‐2 categorization was almost perfect (κ = 0.85; 95% CI: 0.65–1.00).Conclusion: Our study reported a substantial inter‐reader agreement for overall CEUS LI‐RADS categorization, especially for LR‐5 and LR‐M, and major imaging features of HCC, further confirming CEUS LI‐RADS as a valuable and reliable tool for diagnosis of HCC.

17 March 2026 in Clinical Imaging
Verified
Journal Article
Closed access
TXTania Siu Xiao
Tania Siu Xiao
ATAylin Tahmasebi
Aylin Tahmasebi
SKSeyedeh Mohaddeseh Khatami
Seyedeh Mohaddeseh Khatami
CECristina M. Kuon Yeng Escalante
Cristina M. Kuon Yeng Escalante
AMAmr Mohammed
Amr Mohammed
JCJesse Civan
Jesse Civan

1 January 2018 in CIENCIA UNEMI
Verified
Journal Article
Open access
PDF file
SSSunny Sánchez-Giler
Sunny Sánchez-Giler
AHAlan Herrera-Vásquez
Alan Herrera-Vásquez
CCClaudia Castillo-Zambrano
Claudia Castillo-Zambrano
LSLuis Solórzano-Alava
Luis Solórzano-Alava
DZDolores Zambrano-Castro
Dolores Zambrano-Castro
GCGenaro Cucalón-González
Genaro Cucalón-González
Virus Epstein Barr (VEB) ha sido relacionado con una serie de tumores malignos de origen epitelial y linfoide. Existe una clara correlación entre este virus y enfermedades linfoproliferativas como Linfoma de Burkitt (LB), Linfoma Hodgkin (LH), Linfoma no Hodgkin (LNH) y carcinoma gástrico. Se han desarrollado diversas técnicas para la detección de VEB en células tumorales: hibridación in situ (RISH) que detecta RNAs (ácido ribonucleico) pequeños codificados para VEB (EBERs) en las células con infección latente, considerado el estándar de oro para la identificación del virus; la reacción en cadena de la polimerasa (PCR) que permite la detección de la cepa viral y representa un ensayo importarte en el diagnóstico del virus. Se realizó un estudio retrospectivo a partir de muestras de tejidos en parafina de pacientes con linfoma y se buscó al virus mediante PCR y RISH. La prevalencia del virus fue de 58,82%, el género más afectado fue el masculino y el grupo más afectado fue el de 31/40 años. La presencia del virus fue similar en ambos tipos de linfoma: Hodking y No Hodking. La técnica de RISH se mostró más eficiente para detectar la presencia del virus. AbstractEpstein Barr Virus (EBV) is linked to a number of malignant tumors of epithelial and lymphoid origin. There is a strong correlation between this virus and lymphoproliferative diseases such as Burkitt's lymphoma (BL), Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) and gastric carcinoma. There are various techniques developed to detect EBV in tumor cells: in situ hybridization (ISH) detects small coded RNAs (ribonucleic acid) to VEB (EBERs) in latently infected cells. This is considered the gold standard for virus identification. The polymerase chain reaction (PCR) allows the detection of the viral strain and represents an important fact in the virus diagnose. We conducted a retrospective study in paraffin from tissue samples of patients with lymphoma and we sought the virus through PCR and RISH. The virus prevalence was 58.82%, the most affected gender was male and the most affected group was 31/40 years. The virus was similar in both types of lymphoma: Hodgkin and non-Hodgkin. RISH technique seemed to be more efficient to detect the virus.